These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32359845)

  • 1. Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapy.
    Nasioudis D; Ko EM; Haggerty AF; Cory L; Giuntoli RL; Burger RA; Morgan MA; Latif NA
    Gynecol Oncol; 2020 Jun; 157(3):613-618. PubMed ID: 32359845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of lymphadenectomy on prognosis and survival of clinically apparent early-stage malignant ovarian germ cell tumors.
    Qin B; Xu W; Li Y
    Jpn J Clin Oncol; 2020 Mar; 50(3):282-287. PubMed ID: 31867612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of lymph node metastasis and prognostic significance of lymphadenectomy in apparent early-stage malignant ovarian sex cord-stromal tumors.
    Nasioudis D; Kanninen TT; Holcomb K; Sisti G; Witkin SS
    Gynecol Oncol; 2017 May; 145(2):243-247. PubMed ID: 28292524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary.
    Mahdi H; Swensen RE; Hanna R; Kumar S; Ali-Fehmi R; Semaan A; Tamimi H; Morris RT; Munkarah AR
    Br J Cancer; 2011 Aug; 105(4):493-7. PubMed ID: 21772335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the surgical management of malignant ovarian germcell tumors.
    Nasioudis D; Mastroyannis SA; Latif NA; Ko EM
    Gynecol Oncol; 2020 Apr; 157(1):89-93. PubMed ID: 32008791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of staging surgery in the treatment of apparent early-stage malignant ovarian germ cell tumours.
    Zhao T; Zhang H; Liu Y; Jiang H; Wang X; Lu Y
    Aust N Z J Obstet Gynaecol; 2016 Aug; 56(4):398-402. PubMed ID: 27135780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors.
    Wang J; Chen R; Li J; Lu X
    Arch Gynecol Obstet; 2020 Dec; 302(6):1441-1450. PubMed ID: 32888090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Lymphadenectomy in Different Stages of Malignant Germ Cell Tumor of the Ovary Based on Propensity Score Matching.
    Chen Y; Ning Y; Zhang Q; Xie Y
    Comb Chem High Throughput Screen; 2018; 21(9):652-661. PubMed ID: 30569854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
    Yang ZJ; Liu ZC; Wei RJ; Li L
    Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
    Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
    Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
    Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma.
    Nasioudis D; Chapman-Davis E; Witkin SS; Holcomb K
    Gynecol Oncol; 2017 Feb; 144(2):414-419. PubMed ID: 27908528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility-preserving surgery for advanced stage ovarian germ cell tumors.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
    Gynecol Oncol; 2017 Dec; 147(3):493-496. PubMed ID: 29021083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of lymphadenectomy in malignant ovarian germ cell tumor.
    Lv B; Liu X; Zheng A; Han L
    Front Oncol; 2023; 13():1143893. PubMed ID: 37139156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery.
    Eoh KJ; Lee JY; Yoon JW; Nam EJ; Kim S; Kim SW; Kim YT
    Oncotarget; 2017 Jun; 8(23):37807-37816. PubMed ID: 27906676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility-sparing surgery for patients with malignant ovarian germ cell tumors: 10 years of clinical experience from a tertiary referral center.
    Mikuš M; Benco N; Matak L; Planinić P; Ćorić M; Lovrić H; Radošević V; Puževski T; Bajt M; Vujić G
    Arch Gynecol Obstet; 2020 May; 301(5):1227-1233. PubMed ID: 32253553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-year analysis of the prevalence of lymph nodes metastasis, oncologic and pregnancy outcomes in apparent early-stage malignant ovarian germ cell tumors.
    Chatchotikawong U; Ruengkhachorn I; Leelaphatanadit C; Phithakwatchara N
    Asian Pac J Cancer Prev; 2015; 16(4):1609-13. PubMed ID: 25743840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More lymph node dissection improves survival in patients with newly diagnosed lymph node-positive penile cancer.
    Mao W; Huang X; Kong M; Fan J; Geng J
    Int Urol Nephrol; 2019 Apr; 51(4):641-654. PubMed ID: 30758771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases.
    Xu W; Li Y
    Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of comprehensive lymphadenectomy for patients with advanced stage ovarian carcinoma and rare histologic sub-types.
    Nasioudis D; Latif NA; Haggerty AF; Giuntoli Ii RL; Kim SH; Ko EM
    Int J Gynecol Cancer; 2021 Aug; 31(8):1132-1136. PubMed ID: 34193526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.